188 related articles for article (PubMed ID: 29327700)
21. Disseminated fusariosis in a patient with bone marrow aplasia.
Chagas DF; Diniz LM; Lucas EA; Nogueira PSE
An Bras Dermatol; 2020; 95(5):609-614. PubMed ID: 32723611
[TBL] [Abstract][Full Text] [Related]
22. Fusarium skin infection: a case report.
Singhal KV; Saoji V; Saoji SV
Dermatol Online J; 2012 Apr; 18(4):6. PubMed ID: 22559021
[TBL] [Abstract][Full Text] [Related]
23. Fusarium verticillioides fungemia in a liver transplantation patient: successful treatment with voriconazole.
Cocchi S; Codeluppi M; Venturelli C; Bedini A; Grottola A; Gennari W; Cavrini F; Di Benedetto F; De Ruvo N; Rumpianesi F; Gerunda GE; Guaraldi G
Diagn Microbiol Infect Dis; 2011 Dec; 71(4):438-41. PubMed ID: 22083080
[TBL] [Abstract][Full Text] [Related]
24. Successful Combination Therapy of Liposomal Amphotericin B and Caspofungin for Disseminated Fusariosis in a Pediatric Patient With Acute Lymphoblastic Leukemia.
Uemura S; Tamura A; Yamamoto N; Saito A; Nakamura S; Fujiwara T; Tahara T; Kozaki A; Kishimoto K; Ishida T; Hasegawa D; Muraosa Y; Kamei K; Kosaka Y
Pediatr Infect Dis J; 2018 Oct; 37(10):e251-e253. PubMed ID: 29438132
[TBL] [Abstract][Full Text] [Related]
25. A Disseminated Fusarium fujikuroi Species Complex Infection Prior to Allogeneic Hematopoietic Stem Cell Transplantation.
Fujishita K; Oka S; Kamei K; Tani K; Fujisawa Y; Kitamura W; Machida T; Imai T
Acta Med Okayama; 2020 Oct; 74(5):435-441. PubMed ID: 33106701
[TBL] [Abstract][Full Text] [Related]
26. Infections Caused by Fusarium Species in Pediatric Cancer Patients and Review of Published Literature.
Arnoni MV; Paula CR; Auler ME; Simões CCN; Nakano S; Szeszs MW; Melhem MSC; Pereira VBR; Garces HG; Bagagli E; Silva EG; de Macêdo MF; Ruiz LDS
Mycopathologia; 2018 Dec; 183(6):941-949. PubMed ID: 29564632
[TBL] [Abstract][Full Text] [Related]
27. Disseminated fusariosis with cutaneous involvement in hematologic malignancies: report of six cases with high mortality rate.
Hayashida MZ; Seque CA; Enokihara MMSES; Porro AM
An Bras Dermatol; 2018; 93(5):726-729. PubMed ID: 30156626
[TBL] [Abstract][Full Text] [Related]
28. A retrospective cohort of invasive fusariosis in the era of antimould prophylaxis.
Fernández-Cruz A; Semiglia MA; Guinea J; Martínez-Jiménez MDC; Escribano P; Kwon M; Rodríguez-Macías G; Chamorro-de-Vega E; Rodríguez-González C; Navarro R; Galar A; Sánchez-Carrillo C; Díez-Martín JL; Muñoz P
Med Mycol; 2020 Apr; 58(3):300-309. PubMed ID: 31231772
[TBL] [Abstract][Full Text] [Related]
29. Invasive fusariosis.
Nucci M; Anaissie E
Clin Microbiol Rev; 2023 Dec; 36(4):e0015922. PubMed ID: 37937988
[TBL] [Abstract][Full Text] [Related]
30. Combination therapy of voriconazole and terbinafine for disseminated fusariosis: case report and literature review.
Inano S; Kimura M; Iida J; Arima N
J Infect Chemother; 2013 Dec; 19(6):1173-80. PubMed ID: 23564310
[TBL] [Abstract][Full Text] [Related]
31. Nasal cutaneous infection in a healthy boy caused by Fusarium moniliforme.
Yan X; Yu C; Shi Z; Wang S; Zhang F
Pediatr Dermatol; 2013; 30(4):e43-5. PubMed ID: 23360372
[TBL] [Abstract][Full Text] [Related]
32. Fungaemia caused by Fusarium proliferatum in a patient without definite immunodeficiency.
Dananché C; Cassier P; Sautour M; Gautheron N; Wegrzyn J; Perraud M; Bienvenu AL; Nicolle MC; Boibieux A; Vanhems P
Mycopathologia; 2015 Feb; 179(1-2):135-40. PubMed ID: 25253233
[TBL] [Abstract][Full Text] [Related]
33. [Skin infections caused by Fusarium].
Brasch J
Hautarzt; 2012 Nov; 63(11):872-6. PubMed ID: 22948296
[TBL] [Abstract][Full Text] [Related]
34. Invasive Fusariosis: A Single Pediatric Center 15-Year Experience.
Schwartz KL; Sheffield H; Richardson SE; Sung L; Morris SK
J Pediatric Infect Dis Soc; 2015 Jun; 4(2):163-70. PubMed ID: 26407418
[TBL] [Abstract][Full Text] [Related]
35. The Use of FDG PET-CT Imaging for the Assessment of Early Antifungal Treatment Response in Disseminated Fusariosis.
Seban RD; Bonardel G; Guernou M; Lussato D; Queneau M
Clin Nucl Med; 2017 Jul; 42(7):569-570. PubMed ID: 28481795
[TBL] [Abstract][Full Text] [Related]
36. Antimold Prophylaxis May Reduce the Risk of Invasive Fusariosis in Hematologic Patients with Superficial Skin Lesions with Positive Culture for Fusarium.
Varon AG; Nouér SA; Barreiros G; Trope BM; Akiti T; Nucci M
Antimicrob Agents Chemother; 2016 Dec; 60(12):7290-7294. PubMed ID: 27671065
[TBL] [Abstract][Full Text] [Related]
37. Airway complication contributing to disseminated fusariosis after lung transplantation.
Terasaki JM; Shah SK; Schnadig VJ; Valentine VG
Transpl Infect Dis; 2014 Aug; 16(4):621-4. PubMed ID: 24890670
[TBL] [Abstract][Full Text] [Related]
38. Urinary Tract Infection (UTI) Caused by Fusarium proliferatum in an Agranulocytosis Patient and a Review of Published Reports.
Su H; Zhang Q; Li L; Zhao Y; Zhu J; Zhu M
Mycopathologia; 2016 Feb; 181(1-2):131-5. PubMed ID: 26346378
[TBL] [Abstract][Full Text] [Related]
39. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand.
Chariyalertsak S; Supparatpinyo K; Sirisanthana T; Nelson KE
Clin Infect Dis; 2002 Jan; 34(2):277-84. PubMed ID: 11740718
[TBL] [Abstract][Full Text] [Related]
40. [Fusariosis diagnosed in the laboratory of an UH in Tunisia: epidemiological, clinical and mycological study].
Néji S; Trabelsi H; Cheikhrouhou F; Sellami H; Guidara R; Trigui A; Feki J; Boudaya S; Turki H; Makni F; Ayadi A
J Mycol Med; 2013 Jun; 23(2):130-5. PubMed ID: 23725904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
